Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 121 Neoplasms, Plasma Cell 36 Neoplasms 14 Carcinoma, Hepatocellular 13 Recurrence 12 Brain Neoplasms 12 Prostatic Neoplasms 11 Melanoma 11 Central Nervous System Neoplasms 11 Glioblastoma 10 Leukemia 9 Carcinoma, Non-Small-Cell Lung 9 Leukemia, Lymphocytic, Chronic, B-Cell 8 Gliosarcoma 8 Waldenstrom Macroglobulinemia 7 Sarcoma 7 Lung Neoplasms 7 Glioma 7 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Liver Neoplasms 6 Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5 Lymphoma, Mantle-Cell 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma 5 Kidney Neoplasms 5 Immunoglobulin Light-chain Amyloidosis 5 Myelodysplastic-Myeloproliferative Diseases 4 Lymphoma, Follicular 4

Interventions

Cisplatin 30 Magnetic Resonance Spectroscopy 21 Radiotherapy 20 pembrolizumab 18 Specimen Handling 17 Cetuximab 16 Biopsy 13 Radiotherapy, Intensity-Modulated 12 Radiation 11 Paclitaxel 11 Carboplatin 11 Surveys and Questionnaires 10 Fluorouracil 10 Drug Therapy 10 1,2-diaminocyclohexaneplatinum II citrate 10 Platinum 9 Surgical Procedures, Operative 8 X-Rays 7 Taxes 7 Celecoxib 7 Standard of Care 6 Sentinel Lymph Node Biopsy 6 Observation 5 Nivolumab 5 cemiplimab 4 Metformin 4 Interviews as Topic 4 Immunohistochemistry 4 Fluorodeoxyglucose F18 4 Docetaxel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mouth Neoplasms × Thalidomide × Clear all

NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

National Health Research Institutes, Taiwan

Phase 2/3 Terminated

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡